- 收听数
- 0
- 性别
- 保密
- 听众数
- 77
- 最后登录
- 2024-3-23
- QQ
- UID
- 8996
- 阅读权限
- 30
- 帖子
- 3117
- 精华
- 0
- 在线时间
- 821 小时
- 注册时间
- 2014-4-10
- 科研币
- 25
- 速递币
- 21733
- 娱乐币
- 1672
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders | 年|卷|期 | Journal of Medicinal Chemistry, 60(18), 7677-7702; 2017 | 链接 | http://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00807 |
|
|